Remote Monitored Systems update on the Pharm2Farm anti-viral mask project

Remote Monitored Systems plc (LON:RMS) has noted the following announcement published by Braveheart Investment Group in respect of Pharm 2 Farm Limited. As announced on 21 August 2020, RMS has signed a binding Share Purchase Agreement for the acquisition of 100% of the share capital of P2F. Completion of the Acquisition remains subject to regulatory and RMS shareholder approval. The full text of the Braveheart announcement is set out below.

Update on the Pharm2Farm anti-viral mask project

Braveheart Investment Group (LON:BRH) has announced that Pharm 2 Farm Limited has placed an order for an automated face mask production line which is expected to be delivered in November 2020 and commissioned by the end of December 2020.

The face mask production line, which is manufactured in Europe, has the capacity to produce up to five million standard or anti-viral face masks per month.

Conventional surgical type masks typically comprise of three layers, with the inner layer acting as a physical barrier to viruses and bacteria. However, they are only recommended for up to two hours of continual use as this layer can become moist and fail, thereby allowing the virus to penetrate though. P2F has developed a second defensive layer that incorporates its own nanotechnology, which is engineered to kill viruses and bacteria. Combining this new active layer with the physical barrier layer, to produce four layer (ply) masks, is expected to improve user safety over a prolonged use.  This new material is currently undergoing testing, specifically, with respect to the time taken to kill viruses, including COVID-19. These tests are, being undertaken at the University of Nottingham and results are expected by the beginning of October. Following a satisfactory outcome of the tests undertaken at the University of Nottingham, it is envisaged that manufacture of the anti-viral face masks will commence in the first quarter of 2021. In the event that these tests do not provide a satisfactory outcome, the production line will be used to produce conventional surgical type masks, which P2F believe could still be produced on a profitable basis.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Remote Monitored Systems Plc

More articles like this

Face masks are back for many Americans

Face mask requirements are returning to the United States in some communities and workplaces, along with directives for mandatory coronavirus vaccinations, in a new push to curb the easily transmissible delta variant of the infection that

Face masks sales soar after fears rise amidst Freedom Day

Freedom day has arrived… But despite the lifting of Covid restrictions, many experts are warning that Coronavirus infections will continue to rise. Professor Neil Ferguson, from Imperial College London and a member of the Scientific Advisory Group for Emergencies

RMS signs agreement with PIC Consultants

Remote Monitored Systems has announced that it has signed an agreement with PIC Consultants Ltd. to supply high quality retail hydroponic nutrients for distribution in the UK market. The London-listed tech company said that under the

Remote Monitored Systems signs hydroponics agreement

Remote Monitored Systems PLC announced on Monday that it has signed an agreement with PIC Consultants Ltd. to supply high quality retail hydroponic nutrients for distribution in the UK market. The London-listed tech company said that

Remote Monitored Systems growing revenues of £104k

Remote Monitored Systems plc (LON:RMS) has announced its final results for the year end 31 December 2020. Company Highlights Financials • Growing revenues of £104k (2019: £52k) • Losses increased to £1.53m (2019: £0.59m) including share